These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15638708)

  • 1. Synthetic hammerhead ribozymes as therapeutic tools to control disease genes.
    Citti L; Rainaldi G
    Curr Gene Ther; 2005 Feb; 5(1):11-24. PubMed ID: 15638708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribozymes as therapeutic tools for genetic disease.
    Phylactou LA; Kilpatrick MW; Wood MJ
    Hum Mol Genet; 1998; 7(10):1649-53. PubMed ID: 9735387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribozymes in the age of molecular therapeutics.
    Bagheri S; Kashani-Sabet M
    Curr Mol Med; 2004 Aug; 4(5):489-506. PubMed ID: 15267221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrozymes are a unique family of non-autonomous retrotransposons with hammerhead ribozymes that propagate in plants through circular RNAs.
    Cervera A; Urbina D; de la Peña M
    Genome Biol; 2016 Jun; 17(1):135. PubMed ID: 27339130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular selection of trans-cleaving hammerhead ribozymes.
    Huang X; Zhao Y; Pu Q; Liu G; Peng Y; Wang F; Chen G; Sun M; Du F; Dong J; Cui X; Tang Z; Mo X
    Nucleic Acids Res; 2019 Mar; 47(5):2514-2522. PubMed ID: 30649474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and validation of therapeutic hammerhead ribozymes for autosomal dominant diseases.
    Fritz JJ; Gorbatyuk M; Lewin AS; Hauswirth WW
    Methods Mol Biol; 2004; 252():221-36. PubMed ID: 15017052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNAs with hammerhead ribozymes encoded in eukaryotic genomes: The enemy at home.
    de la Peña M; Cervera A
    RNA Biol; 2017 Aug; 14(8):985-991. PubMed ID: 28448743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A computational approach to predict suitable target sites for trans-acting minimal hammerhead ribozymes.
    Mercatanti A; Lande C; Citti L
    Methods Mol Biol; 2012; 848():337-56. PubMed ID: 22315079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic hammerhead ribozymes as tools in gene expression.
    Lyngstadaas SP
    Crit Rev Oral Biol Med; 2001; 12(6):469-78. PubMed ID: 11806517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
    Phylactou LA; Tsipouras P; Kilpatrick MW
    Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of hammerhead ribozymes in the treatment of hyper-proliferative diseases.
    Grassi G; Dawson P; Guarnieri G; Kandolf R; Grassi M
    Curr Pharm Biotechnol; 2004 Aug; 5(4):369-86. PubMed ID: 15320768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribozymes: from mechanistic studies to applications in vivo.
    Ohkawa J; Koguma T; Kohda T; Taira K
    J Biochem; 1995 Aug; 118(2):251-8. PubMed ID: 8543555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural similarities between hammerhead ribozymes and the spliceosomal RNAs could be responsible for lack of ribozyme cleavage in yeast.
    Castanotto D; Li H; Chow W; Rossi JJ; Deshler JO
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):1-13. PubMed ID: 9512091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
    Sun LQ; Wang L; Gerlach WL; Symonds G
    Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of structure in a long target RNA on ribozyme cleavage efficiency.
    Campbell TB; McDonald CK; Hagen M
    Nucleic Acids Res; 1997 Dec; 25(24):4985-93. PubMed ID: 9396806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of hammerhead ribozymes to modulate endogenous gene expression for functional studies.
    Fritz JJ; Lewin A; Hauswirth W; Agarwal A; Grant M; Shaw L
    Methods; 2002 Oct; 28(2):276-85. PubMed ID: 12413427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly motif- and organism-dependent effects of naturally occurring hammerhead ribozyme sequences on gene expression.
    Wurmthaler LA; Klauser B; Hartig JS
    RNA Biol; 2018 Feb; 15(2):231-241. PubMed ID: 29106331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of circular RNAs and trans-cleaving catalytic RNAs by rolling transcription of circular DNA oligonucleotides encoding hairpin ribozymes.
    Diegelman AM; Kool ET
    Nucleic Acids Res; 1998 Jul; 26(13):3235-41. PubMed ID: 9628924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNAs Biogenesis in Eukaryotes Through Self-Cleaving Hammerhead Ribozymes.
    de la Peña M
    Adv Exp Med Biol; 2018; 1087():53-63. PubMed ID: 30259357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.